Buscar resultados de ensayos clínicos
Nut Hypersensitivity - 32 Studies Found
| Estado | Estudiar |
| Withdrawn |
Nombre del estudio: Peanut Allergy Oral Immunotherapy Desensitization Condición: Peanut Allergy Fecha: 2011-07-27 Intervenciones:
|
| Active, not recruiting |
Nombre del estudio: Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) Condición: Peanut Allergy Fecha: 2015-12-17 Intervenciones:
|
| Recruiting |
Nombre del estudio: Boiled Peanut Oral Immunotherapy for the Treatment of Peanut Allergy: a Pilot Study Condición: IgE Mediated Peanut Allergy Fecha: 2014-05-24 Intervenciones:
|
| Suspended |
Nombre del estudio: The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy Condición: Peanut Allergy Fecha: 2013-07-08 Intervenciones: Drug: Peanut Dissolving Film |
| Completed |
Nombre del estudio: Placebo-Controlled Study to Investigate ANB020 Activity in Adult Patients With Peanut Allergy Condición: Peanut Allergy Fecha: 2016-09-26 Intervenciones:
|
| Completed |
Nombre del estudio: Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy Condición: Peanut Allergy Fecha: 2010-07-24 Intervenciones:
|
| Completed |
Nombre del estudio: Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy Condición: Peanut Allergy Fecha: 2012-08-17 Intervenciones:
|
| Completed |
Nombre del estudio: Oral Peanut Immunotherapy for Peanut Allergic Patients Condición: Peanut Hypersensitivity Fecha: 2013-05-24 Intervenciones: Drug: Peanut protein Subjects will receive increasing amounts of peanut protein over the modified rush p |
| Completed |
Nombre del estudio: A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g Condición: Peanut Hypersensitivity Fecha: 2006-09-26 Intervenciones: Drug: omalizumab SC repeating dose |
| Completed |
Nombre del estudio: Development of an Algorithm to Better Predict Clinical Responsiveness to Peanut Condición: Peanut Hypersensitivity Fecha: 2005-10-20 Intervenciones:
|